<DOC>
	<DOCNO>NCT00846339</DOCNO>
	<brief_summary>Bupropion different effect D2 dopamine receptor accord genotype .</brief_summary>
	<brief_title>PET Imaging Study Occupancy Dopamine D2 Receptors Genotypes After Bupropion Administration</brief_title>
	<detailed_description>Open , one arm , single sequence , 2-period , study stratify 2 DRD2 genotype group For subject volunteer cease smoking , genotype investigate . Twelve subject enrol ( 6 - DRD2 Taq1A1 allele , 6 - DRD2 Taq1A2 homozygotes ) . Subjects receive baseline raclopride PET ( High Specific Activity , Low Specific Activity ) . - Period 1 Subjects receive 150 mg bupropion SR every day . After 1 week medication , pharmacokinetic PET study perform . - Period 2 Subjects receive 150 mg bupropion SR twice day . After 1 week medication , pharmacokinetic PET study perform .</detailed_description>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Active smoker ( 10 cigarette per day past 2 year ) Medical psychiatric comorbidity Hypersensitive bupropion</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Smoking cessation</keyword>
	<keyword>Bupropion</keyword>
</DOC>